|
Home | Technology News Search Engine:
|
|
|
|
Home: Technology News:
|
|
|
(IT-NEWSWIRE.COM, August 30, 2019 ) Artificial Blood Market:
• Artificial blood to made act as a substitute for red blood cells. While true blood perform different functions but artificial blood is designed for the purpose of transporting oxygen and carbon dioxide through the body.
• Perfluorocarbon emulsions are based on inert components which replace hydrogen and fluorine. Hemoglobin-based oxygen carriers consist of hemoglobin derived products sourced from human blood, bovine blood, microorganisms, and transgenic animals
Artificial Blood Market Drivers:
• As per the 2011 analysis from the national blood collection and utilization survey, the US could see a shortfall of around 4 million units of blood annually by 2030.
• According to the National center for biotechnology information in 2019, estimated that annual incidence of the shock of any etiology is 0.3- 0.7 per 1000 cases with hemorrhagic shock being the most common in the intensive care unit.
Artificial Blood Market Restraints:
• Major factors hindering the global artificial blood market during the forecast period are expansive, lack of awareness and adverse side effects associated with the usage of the artificial blood.
Artificial Blood Market Segmentation Analysis:
• Global artificial blood market is segmented by product type, by source, by application, and by distribution channel. By product, type includes hemoglobin-based oxygen carriers and perfluorocarbon emulsion, and by source includes human hemoglobin, animal hemoglobin, stem cells, synthetic polymers, and others.
• Hemoglobin-based oxygen carriers dominate the global artificial blood market during the forecast period owing to its extended product portfolio by key players compared with the perfluorocarbon emulsions, key players investing in the development of advanced hemoglobin-based oxygen carrier’s majority of them are in clinical trials.
Artificial Blood Market Geographical Analysis:
• North America dominates the global artificial blood market during the forecast period owing to the rise in trauma deaths due to excessive blood loss prior to the admission, increase in the prevalence of anemia and blood-related disorders across the region and leading to the development of novel artificial blood.
• According to Health 24 in 2016, more than 20,000 trauma deaths in the united states occur due to the blood prior to arriving at the treatment center.
Artificial Blood Market Competitive Analysis:
• In February 2019, Seattle Based medical technology company Healionics raised 3.8 million in funding to support the development of an artificial blood vessel called STARgraft for patients who undergo dialysis treatment.
Major market players in the artificial blood market are
• FLUORO2 Therapeutics,
• Kalocyte, Hemarina,
• North Field Laboratories,
• others.
View full report: https://www.datamintelligence.com/research-report/artificial-blood-market
Download free sample: https://www.datamintelligence.com/download-sample/artificial-blood-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1-888-702-9626
Website: www.datamintelligence.com
Company: DataM Intelligence
Contact: Sai Kiran
Phone: +1 877 441 4866
Email: pr[@]datamintelligence.com
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
|
Technology News Headlines
|
|
|
|
|
Technology Business Video Feed
|
|
More Technology Video Feeds
|
|
|
